MedTrace Logo

Study of Serum Hepcidin Rate Variations During Menstrual Cycle

NCT01764412 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 147

Last updated 2015-03-30

No results posted yet for this study

Summary

Hepcidin is the major hormone regulating Iron Metabolism. In a normal organism decrease iron stock causes a decrease in hepcidin synthesis thus promoting intestinal absorption of iron.

The interpretation of hepcidin dosage results requires to know the physiological variations of this hormone.

This study investigate whether there are significant variations in the values of serum hepcidin rates during the menstrual cycle in order to make recommendations on the practical dosage determination of hepcidin in premenopausal women.

Conditions

  • Healthy Women

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Fabrice lainé, MD · CHU de Rennes - CIC INSERM 0203

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-03-31
Completion
2015-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01764412 on ClinicalTrials.gov